Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Pancreatic stellate cells (PSCs) differentiate into cancer-associated fibroblasts (CAFs) that produce desmoplastic stroma, thereby modulating disease progression and therapeutic response in pancreatic ductal adenocarcinoma (PDA). However, it is unknown whether CAFs uniformly carry out these tasks or if subtypes of CAFs with distinct phenotypes in PDA exist. We identified a CAF subpopulation with elevated expression of α-smooth muscle actin (αSMA) located immediately adjacent to neoplastic cells in mouse and human PDA tissue. We recapitulated this finding in co-cultures of murine PSCs and PDA organoids, and demonstrated that organoid-activated CAFs produced desmoplastic stroma. The co-cultures showed cooperative interactions and revealed another distinct subpopulation of CAFs, located more distantly from neoplastic cells, which lacked elevated αSMA expression and instead secreted IL6 and additional inflammatory mediators. These findings were corroborated in mouse and human PDA tissue, providing direct evidence for CAF heterogeneity in PDA tumor biology with implications for disease etiology and therapeutic development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, TGF-β influences CAF expression of cytokines and chemokines that act on cancer, endothelial and/or immune cells, such as HGF245, VEGF, IL-6, IL-8, MCP1, PGE2 and CXCL12229,257–262.”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [229]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In pancreatic cancer, CAFs most proximal to the cancer cells exhibit a myoCAF phenotype, with high TGFβ-driven αSMA expression and a contractile phenotype33.”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [33]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“With respect to CAFs and pancreatic cancer, it has been established that coculture of murine PSCs and PDAC tumor organoids leads to CAF differentiation into two subtypes -one with elevated expression of α -SMA (myo fi broblast-like CAFs) and the other with high expression of IL-6 (in fl ammatory CAFs) [61].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [61]
The cited source says what the claim attributes to it.
In the citing paper
“CAFs that are in close proximity to cancer cells present a myo fi broblast-like phenotype (myCAF) de fi ned by a high expression of α -SMA”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [61]
The cited source says what the claim attributes to it.
In the citing paper
“whereas CAFs distant from cancer cells barely express α -SMA but secrete high amounts of in fl ammatory cytokine IL-6 (iCAF)”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [61]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Differential expression analysis for sequence count data
Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Self-citationCre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Self-citation
Cited by
Items 501–600 of 1,008
The Interplay of the Extracellular Matrix and Stromal Cells as a Drug Target in Stroma-Rich Cancers
Kozlova, N., Grossman, J. E., Iwanicki, M. P., & Muranen, T. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.01.001 · Cited by 73
Zhu, Y., Chen, S., Zeng, L., Liu, G., Jiang, W., Zhang, X., Chen, S., Guo, J., Jian, X., Ouyang, J., et al. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23150 · Cited by 78
The Paradox of Cancer Immune Exclusion: Immune Oncology Next Frontier
Pai, S. I., Cesano, A., & Marincola, F. M. (2020) · Cancer treatment and research · doi:10.1007/978-3-030-38862-1_6 · Cited by 81
Aoki, S., Inoue, K., Klein, S., Halvorsen, S. C., Chen, J., Matsui, A., Nikmaneshi, M. R., Kitahara, S., Hato, T., Chen, X., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-322493 · Cited by 78
Chen, H., Guo, Q., Chu, Y., Li, C., Zhang, Y., Liu, P., Zhao, Z., Wang, Y., Luo, Y., Zhou, Z., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121599 · Cited by 76
Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression
Laplagne, C., Domagala, M., Le Naour, A., Quemerais, C., Hamel, D., Fournié, J.-J., Couderc, B., Bousquet, C., Ferrand, A., & Poupot, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194719 · Cited by 72
Upadhrasta, S., & Zheng, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091472 · Cited by 73
Reese, M., & Dhayat, S. A. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01149-4 · Cited by 88
Control of Dendritic Cell Function Within the Tumour Microenvironment
Hari‐Gupta, Y., Khanom, A., & Acton, S. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.733800 · Cited by 77
Iida, T., Mizutani, Y., Esaki, N., Ponik, S. M., Burkel, B. M., Weng, L., Kuwata, K., Masamune, A., Ishihara, S., Haga, H., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02288-9 · Cited by 85
Blair, A. B., Wang, J., Davelaar, J., Baker, A., Li, K., Niu, N., Wang, J., Shao, Y., Funes, V., Li, P., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.06.027 · Cited by 77
Boelaars, K., Rodríguez, E., Huinen, Z. R., Liu, C., Wang, D., Springer, B. O., Olesek, K., Kruijssen, L. J. W., van Ee, T., Lindijer, D., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06087-8 · Cited by 82
Self-citationChronic Inflammation and Blood CancerPreprint
Tzenios, N., Tazanios, M., & Chahine, M. A. (2022) · Preprints.org · doi:10.20944/preprints202211.0365.v1 · Cited by 72
Crawford, H. C., di Magliano, M. P., & Banerjee, S. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.042 · Cited by 77
Zhan, S., Liu, Z., Zhang, M., Guo, T., Quan, Q., Huang, L., Guo, L., Cao, L., & Zhang, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01466 · Cited by 78
Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects
Li, K., Yuan, J., Trafton, D., Wang, J., Niu, N., Yuan, C., Liu, X., & Zheng, L. (2020) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2020.01.002 · Cited by 81
Cohen, C., Mhaidly, R., Croizer, H., Kieffer, Y., Leclère, R., Vincent‐Salomon, A., Robley, C., Anglicheau, D., Rabant, M., Sannier, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44886-z · Cited by 92
A Subset of Cancer-Associated Fibroblasts Determines Therapy Resistance
Huelsken, J., & Hanahan, D. (2018) · Cell · doi:10.1016/j.cell.2018.01.028 · Cited by 72
The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives
Wu, Y., Zhang, C., Jiang, K., Werner, J., Bazhin, A. V., & D’Haese, J. G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.621937 · Cited by 71
Jena, B. C., Das, C. K., Bharadwaj, D., & Mandal, M. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188416 · Cited by 80
Wong, K. Y., Cheung, A. H. K., Chen, B., Chan, W. N., Yu, J. Q., Lo, K. W., Kang, W., & To, K. F. (2022) · International Journal of Cancer · doi:10.1002/ijc.34127 · Cited by 81
Mechanisms of PDAC subtype heterogeneity and therapy response
Espinet, E., Klein, L., Puré, E., & Singh, S. K. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.08.005 · Cited by 93
Cancer-associated fibroblasts in cancer drug resistance and cancer progression: a review
Masuda, H. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02566-x · Cited by 95
Connecting the Metabolic and Immune Responses to Cancer
Flint, T. R., Fearon, D. T., & Janowitz, T. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.03.001 · Cited by 72
Self-citationWaise, S., Parker, R., Rose-Zerilli, M. J. J., Layfield, D. M., Wood, O., West, J., Ottensmeier, C. H., Thomas, G. J., & Hanley, C. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-45842-4 · Cited by 70
A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer
Bonneau, C., Eliès, A., Kieffer, Y., Bourachot, B., Ladoire, S., Pelon, F., Hequet, D., Guinebretière, J.-M., Blanchet, C., Vincent-Salomon, A., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01311-9 · Cited by 70
Intercellular Communication in Tumor Biology: A Role for Mitochondrial Transfer
Herst, P. M., Dawson, R. H., & Berridge, M. V. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00344 · Cited by 73
Gui, J., Zahedi, F., Ortiz, A., Cho, C., Katlinski, K. V., Alicea-Torres, K. M., Li, J., Todd, L., Zhang, H., Beiting, D. P., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0064-0 · Cited by 74
Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses
Raimondi, G., Mato-Berciano, A., Pascual-Sabater, S., Rovira-Rigau, M., Cuatrecasas, M., Fondevila, C., Sánchez-Cabús, S., Begthel, H., Boj, S. F., Clevers, H., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102786 · Cited by 68
Self-citationCXCR2 signaling promotes secretory cancer‐associated fibroblasts in pancreatic ductal adenocarcinoma
Awaji, M., Saxena, S., Wu, L., Prajapati, D. R., Purohit, A., Varney, M. L., Kumar, S., Rachagani, S., Ly, Q. P., Jain, M., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902990r · Cited by 68
Miyazaki, Y., Oda, T., Inagaki, Y., Kushige, H., Saito, Y., Mori, N., Takayama, Y., Kumagai, Y., Mitsuyama, T., & Kida, Y. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-84058-3 · Cited by 69
Lee, S., Hong, J. H., Kim, J. S., Yoon, J. S., Chun, S. H., Hong, S. A., Kim, E. J., Kang, K., Kang, J. L., Ko, Y. H., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.03.021 · Cited by 75
Imlimthan, S., Moon, E. S., Rathke, H. G., Afshar‐Oromieh, A., Rösch, F., Rominger, A., & Gourni, E. (2021) · Pharmaceuticals · doi:10.3390/ph14101023 · Cited by 80
Wang, E., Xiang, K., Zhang, Y., & Wang, X.-F. (2022) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2022.10.001 · Cited by 56
Luo, W., Wen, T., & Qu, X. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02935-3 · Cited by 87
PanIN and CAF transitions in pancreatic carcinogenesis revealed with spatial data integration
Bell, A. T. F., Mitchell, J. T., Kiemen, A. L., Lyman, M. R., Fujikura, K., Lee, J. W., Coyne, E. M., Shin, S. M., Nagaraj, S., Deshpande, A. M., et al. (2024) · Cell Systems · doi:10.1016/j.cels.2024.07.001 · Cited by 80
Macrophages and fibroblasts as regulators of the immune response in pancreatic cancer
Shakiba, M., & Tuveson, D. A. (2025) · Nature Immunology · doi:10.1038/s41590-025-02134-6 · Cited by 97
Self-citationZhang, B., Ye, H., Ren, X., Zheng, S., Zhou, Q., Chen, C., Lin, Q., Li, G., Wei, L., Fu, Z., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.06.005 · Cited by 71
The war against pancreatic cancer in 2020 — advances on all fronts
Jain, T., & Dudeja, V. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00410-4 · Cited by 71
Bienkowska, K., Hanley, C. J., & Thomas, G. J. (2021) · Frontiers in Oral Health · doi:10.3389/froh.2021.686337 · Cited by 76
Metastasis: crosstalk between tissue mechanics and tumour cell plasticity
Coban, B., Bergonzini, C., Zweemer, A. J. M., & Danen, E. H. J. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01150-7 · Cited by 71
Koustoulidou, S., Hoorens, M. W. H., Dalm, S. U., Mahajan, S., Debets, R., Seimbille, Y., & de Jong, M. (2021) · Cancers · doi:10.3390/cancers13051100 · Cited by 73
Peng, H. Y., Yang, M., Feng, K., Lv, Q., & Zhang, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01887-0 · Cited by 76
Johnson, J., Bergman, D. R., da Rocha, H. L., Zhou, D. L., Cramer, E. M., McLean, I. C., Dance, Y. W., Booth, M. I., Nicholas, Z., Lopez-Vidal, T. Y., et al. (2025) · Cell · doi:10.1016/j.cell.2025.06.048 · Cited by 100
Role of pericytes in the retina
Santos, G. S. P., Prazeres, P. H. D. M., Mintz, A., & Birbrair, A. (2017) · Eye · doi:10.1038/eye.2017.220 · Cited by 76
Yamauchi, M., Gibbons, D. L., Zong, C. C., Fradette, J. J., Bota‐Rabassedas, N., & Kurie, J. M. (2020) · Matrix Biology · doi:10.1016/j.matbio.2020.05.001 · Cited by 73
Mueller, A. C., Piper, M., Goodspeed, A. E., Bhuvane, S., Williams, J. S., Bhatia, S., Phan, A. V., Court, B. V., Zolman, K. L., Peña, B., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3892 · Cited by 68
Fang, L., Che, Y., Zhang, C., Huang, J., Lei, Y., Lu, Z., Sun, N., & He, J. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13053 · Cited by 69
Three-dimensional colon cancer organoids model the response to CEA-CD3 T-cell engagers
Teijeira, Á., Miguéliz, I., Garasa, S., Karanikas, V., Luri‐Rey, C., Cirella, A., Olivera, I., Cañamero, M., Álvarez, M., Ochoa, M. C., et al. (2022) · Theranostics · doi:10.7150/thno.63359 · Cited by 73
Cancer Associated Fibroblasts - An Impediment to Effective Anti-Cancer T Cell Immunity
Koppensteiner, L., Mathieson, L., O’Connor, R. A., & Akram, A. R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.887380 · Cited by 76
Integrin α11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer
Schnittert, J., Bansal, R., Mardhian, D. F., van Baarlen, J., Östman, A., & Prakash, J. (2019) · The FASEB Journal · doi:10.1096/fj.201802336r · Cited by 74
Stromal Cells in the Pathogenesis of Inflammatory Bowel Disease
Barnhoorn, M. C., Hakuno, S. K., Bruckner, R. S., Rogler, G., Hawinkels, L. J. A. C., & Scharl, M. M. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa009 · Cited by 73
Dzobo, K., & Dandara, C. (2020) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2020.0023 · Cited by 66
Iwamoto, C., Ohuchida, K., Shinkawa, T., Okuda, S., Otsubo, Y., Okumura, T., Sagara, A., Koikawa, K., Ando, Y., Shindo, K., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.04.013 · Cited by 70
Cancer immune exclusion: breaking the barricade for a successful immunotherapy
Bruni, S., Mercogliano, M. F., Mauro, F. L., Russo, R. I. C., & Schillaci, R. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1135456 · Cited by 79
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC
Zhou, X., An, J., Kurilov, R., Brors, B., Hu, K., Peccerella, T., Roessler, S. K., Pfütze, K., Schulz, A., Wolf, S., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00628-6 · Cited by 83
Mathieson, L., Koppensteiner, L., Pattle, S. B., Dorward, D. A., O’Connor, R. A., & Akram, A. R. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02671-1 · Cited by 78
Improving outcomes of patients with pancreatic cancer
Dreyer, S. B., Beer, P. A., Hingorani, S. R., & Biankin, A. V. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01019-9 · Cited by 81
The tumour microenvironment in pancreatic cancer — new clinical challenges, but more opportunities
Kung, H., Zheng, K., Zimmerman, J. W., & Zheng, L. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01077-z · Cited by 99
Experimental models of pancreatic cancer desmoplasia
Suklabaidya, S., Dash, P., Das, B., Suresh, V., Sasmal, P. K., & Senapati, S. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.127 · Cited by 71
Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer
Khomiak, A., Brunner, M., Kordes, M., Lindblad, S., Miksch, R. C., Öhlund, D., & Regel, I. (2020) · Cancers · doi:10.3390/cancers12113234 · Cited by 73
Self-citationPalamaris, K., Felekouras, E. S., & Sakellariou, S. (2021) · Cancers · doi:10.3390/cancers13215532 · Cited by 76
Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits
Maneshi, P., Mason, J. E., Dongre, M., & Öhlund, D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.787485 · Cited by 73
Self-citationNeuzillet, C., Nicolle, R., Raffenne, J., Tijeras‐Raballand, A., Brunel, A., Astorgues‐Xerri, L., Vacher, S., Arbaretaz, F., Fanjul, M., Hilmi, M., et al. (2022) · The Journal of Pathology · doi:10.1002/path.6011 · Cited by 69
Licaj, M., Mhaidly, R., Kieffer, Y., Croizer, H., Bonneau, C., Meng, A., Djerroudi, L., Mujangi-Ebeka, K., Hocine, H. R., Bourachot, B., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45595-3 · Cited by 72
Piwócka, O., Piotrowski, I., Suchorska, W. M., & Kulcenty, K. I. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1343523 · Cited by 80
Bulin, A., Broekgaarden, M., & Hasan, T. G. (2017) · Scientific Reports · doi:10.1038/s41598-017-16622-9 · Cited by 71
ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling
Pinho, A. V., Van Bulck, M., Chantrill, L., Arshi, M., Sklyarova, T., Herrmann, D., Vennin, C., Gallego-Ortega, D., Mawson, A., Giry-Laterriere, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07497-z · Cited by 64
Organoid Models for Cancer Research
Clevers, H. C., & Tuveson, D. A. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055702 · Cited by 75
Self-citationKadel, D., Zhang, Y., Sun, H.-R., Zhao, Y., Dong, Q.-Z., & Qin, L.-X. (2019) · Cell Biology and Toxicology · doi:10.1007/s10565-019-09461-z · Cited by 63
Establishment of a reference single-cell RNA sequencing dataset for human pancreatic adenocarcinoma
Chijimatsu, R., Kobayashi, S., Takeda, Y., Kitakaze, M., Tatekawa, S., Arao, Y., Nakayama, M., Tachibana, N., Saito, T., Ennishi, D., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104659 · Cited by 71
Zheng, S., Hu, C., Lin, Q., Li, T., Li, G., Tian, Q., Zhang, X., Huang, T., Ye, Y., He, R., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0178 · Cited by 76
Yu, S., Wang, S., Wang, X., & Xu, X. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03518-8 · Cited by 78
Luo, D. Y., Zhou, J., Ruan, S., Zhang, B., Zhu, H., Que, Y., Ying, S., Li, X., Hu, Y., & Song, Z. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07385-7 · Cited by 79
Pergolini, I., Morales-Oyarvide, V., Mino-Kenudson, M., Honselmann, K. C., Rosenbaum, M. W., Nahar, S., Kem, M., Ferrone, C. R., Lillemoe, K. D., Bardeesy, N., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0182855 · Cited by 63
Deiana, M., Castán, J. M. A., Josse, P., Kahsay, A. G., Sánchez, D. P., Morice, K., Gillet, N., Ravindranath, R., Patel, A. K., Sengupta, P., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad365 · Cited by 68
Self-citationZhao, J. J., Ong, C. J., Srivastava, S., Chia, D. K. A., Ma, H., Huang, K. K., Sheng, T., Ramnarayanan, K., Ong, X., Tay, S. T., et al. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.08.007 · Cited by 81
Esophageal Cancer Development: Crucial Clues Arising from the Extracellular Matrix
Palumbo, A., Costa, N. M. D., Pontes, B., de Oliveira, F. L., Lohan-Codeço, M., Pinto, L. F. R., & Nasciutti, L. E. (2020) · Cells · doi:10.3390/cells9020455 · Cited by 65
Osman, A., Afify, S. M., Hassan, G., Fu, X., Seno, A., & Seno, M. (2020) · Cancers · doi:10.3390/cancers12040879 · Cited by 63
Microdissected pancreatic cancer proteomes reveal tumor heterogeneity and therapeutic targets
Large, T. Y. S. L., Mantini, G., Meijer, L. L., Pham, T. V., Funel, N., van Grieken, N. C. T., Kok, B., Knol, J. C., van Laarhoven, H. W. M., Piersma, S. R., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.138290 · Cited by 66
Peng, H., James, C. A., Cullinan, D. R., Hogg, G. D., Mudd, J. L., Zuo, C., Takchi, R., Caldwell, K. E., Liu, J., DeNardo, D. G., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0998 · Cited by 61
Hosein, A. N., Dangol, G., Okumura, T., Roszik, J., Rajapakshe, K., Siemann, M., Zaid, M., Ghosh, B., Monberg, M., Guerrero, P. A., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.12.273 · Cited by 61
Self-citationOrganoid models of the tumor microenvironment and their applications
Xia, T., Du, W., Chen, X., & Zhang, Y.-N. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16578 · Cited by 66
Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasis
Jungwirth, U., van Weverwijk, A., Evans, R. J., Jenkins, L., Vicente, D., Alexander, J. J., Gao, Q., Haider, S., Iravani, M., & Isacke, C. M. (2021) · Nature Communications · doi:10.1038/s41467-021-23583-1 · Cited by 64
Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight
Cortesi, M., Zanoni, M., Pirini, F., Tumedei, M. M., Ravaioli, S., Rapposelli, I. G., Frassineti, G. L., & Bravaccini, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010254 · Cited by 65
Role of the tumor microenvironment in cancer hallmarks and targeted therapy (Review)
Naser, R., Fakhoury, I., El‑Fouani, A., Abi‑Habib, R., & El‑Sibai, M. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5471 · Cited by 61
Lee, Y. E., Go, G.-Y., Koh, E.-Y., Yoon, H.-N., Seo, M., Hong, S.-M., Jeong, J. H., Kim, J.-C., Cho, D., Kim, T. S., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006130 · Cited by 61
Metabolic control of collagen synthesis
Guillard, J., & Schwörer, S. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.07.003 · Cited by 69
Wong, C.-W., Han, H.-W., Tien, Y.-W., & Hsu, S.-H. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.05.013 · Cited by 60
MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy
Gautam, S. K., Sushil Kumar, K., Dam, V., Ghersi, D., Jain, M., & Batra, S. K. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101391 · Cited by 67
Preclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies
Pham, T. D., Shields, M. A., Spaulding, C., Principe, D. R., Li, B., Underwood, P. W., Trevino, J. G., Bentrem, D. J., & Munshi, H. G. (2021) · Cancers · doi:10.3390/cancers13030440 · Cited by 67
Sato, R., Imamura, K., Semba, T., Tomita, Y., Saeki, S., Ikeda, K., Komohara, Y., Suzuki, M., Sakagami, T., Saya, H., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3941 · Cited by 59
Yu, Z., Zhang, J., Zhang, Q., Wei, S., Shi, R., Zhao, R., An, L., Grose, R. P., Feng, D., & Wang, H. (2022) · Cell Proliferation · doi:10.1111/cpr.13249 · Cited by 64
Costa, A., Thirant, C., Kramdi, A., Pierre‐Eugène, C., Louis‐Brennetot, C., Blanchard, O., Surdez, D., Gruel, N., Lapouble, E., Pierron, G., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004807 · Cited by 67
Wu, H., Xiang, Z., Huang, G., He, Q., Song, J., Dou, R., Yang, C., Wang, S., & Xiong, B. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.72218 · Cited by 65
Sunami, Y., Häußler, J., & Kleeff, J. H. (2020) · Cancers · doi:10.3390/cancers12123770 · Cited by 69
Sun, R., Zhao, H., Gao, D. S., Ni, A., Li, H., Chen, L., Lu, X., Chen, K., & Lu, B. (2023) · Science Advances · doi:10.1126/sciadv.add7399 · Cited by 71
Overcoming therapy resistance in pancreatic cancer: New insights and future directions
Espona‐Fiedler, M., Patthey, C., Lindblad, S., Sarró, I., & Öhlund, D. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116492 · Cited by 71
Self-citationThe tumor microenvironment is an ecosystem sustained by metabolic interactions
Kay, E. J., & Zanivan, S. R. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115432 · Cited by 77
Filliol, A., & Schwabe, R. F. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1685539 · Cited by 58
Metadata
- Authors
- Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., Chio, I. I. C., Hwang, C.-I., Tiriac, H., Baker, L. A., Engle, D. D., Feig, C., Kultti, A., Egeblad, M., Fearon, D. T., Crawford, J. M., Clevers, H., Park, Y., & Tuveson, D. A.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724 1
- University of Verona (IT)
- University of Cambridge (GB)
- Hofstra University (US)
- Royal Netherlands Academy of Arts and Sciences (NL)
- ORCID
- Öhlund, Daniel
- Biffi, Giulia
- Almeida, Ana S.
- Corbo, Vincenzo
- Oni, Tobiloba E.
- Hearn, Stephen A.
- Lee, Eun Jung
- Chio, Iok In Christine
- Hwang, Chang-Il
- Tiriac, Hervé
- Baker, Lindsey A.
- Engle, Dannielle D.
- Feig, Christine
- Kultti, Anne
- Egeblad, Mikala
- Fearon, Douglas T.
- Crawford, James M.
- Clevers, Hans
- Park, Youngkyu
- Tuveson, David A.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-02-23
- Volume
- 214
- Issue
- 3
- Pages
- 579-596
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5339682
- OpenAlex
- W2590390825
- Cited by
- 2,590
- References
- 58
- Citations by year
- 2026: 349 · 2025: 333 · 2024: 350 · 2023: 343 · 2022: 335 · 2021: 349 · 2020: 260 · 2019: 144 · 2018: 89 · 2017: 36
- FWCI
- 64.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion, other-oa)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Cork Open Research Archive (University College Cork, Ireland) (acceptedVersion, cc-by)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Lustgarten Foundation
- National Institutes of Health (5P30CA45508-26, 5P50CA101955-07, 1U10CA180944-02, 5U01CA168409-5, 1R01CA188134, 1R01CA190092-03, R50CA311506-01, CA101955 UAB/UMN SPORE, 5T32CA148056, F32CA192904)
- Stand Up to Cancer
- STARR foundation (I7-A718)
- DOD (W81XWH-13-PRCRP-IA)
- Swedish Research Council (537-2013-7277)
- Kempe Foundations (JCK-1301)
- Swedish Society of Medicine (SLS-326921, SLS-250831, SLS-175991, SLS-591551)
- Cancer Research Foundation in Northern Sweden (AMP15-793, LP11-1927)
- Human Frontiers Science Program (LT000403/2014, LT000195/2015-L, LT000190/2013)
- Weizmann Institute of Science
- EMBO (ALTF 1203-2014)
- Italian Ministry of Health (FIRB - RBAP10AHJ)
- Associazione Italiana Ricerca Cancro (18718)
- Damon Runyon Cancer Research Foundation (DRG-2165-13)
- National Cancer Institute (1K99CA204725-01A1)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- pancreatic ductal adenocarcinoma, cancer-associated fibroblasts, CAF heterogeneity, pancreatic stellate cells, myofibroblasts, desmoplastic stroma, alpha-smooth muscle actin, interleukin-6, tumor microenvironment, organoid co-culture, tumor-fibroblast interaction
- MeSH terms
- Actins, Animals, Cells, Cultured, Fibroblasts, Humans, Mice, Inbred C57BL, Pancreatic Neoplasms, Cytokines, Carcinoma, Pancreatic Ductal, STAT3 Transcription Factor, Mice, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.